These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20664170)

  • 21. Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice.
    Li Z; Blad CC; van der Sluis RJ; de Vries H; Van Berkel TJ; Ijzerman AP; Hoekstra M
    Br J Pharmacol; 2012 Oct; 167(4):818-25. PubMed ID: 22616721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation.
    Bermudez Y; Benavente CA; Meyer RG; Coyle WR; Jacobson MK; Jacobson EL
    PLoS One; 2011; 6(5):e20487. PubMed ID: 21655214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.
    Lukasova M; Malaval C; Gille A; Kero J; Offermanns S
    J Clin Invest; 2011 Mar; 121(3):1163-73. PubMed ID: 21317532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells.
    Li Z; Li X; Lin S; Chen Y; Ma S; Fu Y; Wei C; Xu W
    Ann Clin Lab Sci; 2017 Nov; 47(6):729-737. PubMed ID: 29263047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Niacin stimulates adiponectin secretion through the GPR109A receptor.
    Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.
    Chen L; So WY; Li SY; Cheng Q; Boucher BJ; Leung PS
    Mol Cell Endocrinol; 2015 Mar; 404():56-66. PubMed ID: 25622782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.
    Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Taggart AK; Cheng K; Carballo-Jane E; Gerard Waters M; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2121-4. PubMed ID: 19307116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.
    Kim HY; Jadhav VB; Jeong DY; Park WK; Song JH; Lee S; Cho H
    Arch Pharm Res; 2015 Jun; 38(6):1019-32. PubMed ID: 25599616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats.
    Shen HC; Ding FX; Deng Q; Wilsie LC; Krsmanovic ML; Taggart AK; Carballo-Jane E; Ren N; Cai TQ; Wu TJ; Wu KK; Cheng K; Chen Q; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2009 Apr; 52(8):2587-602. PubMed ID: 19309152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niacin/β-hydroxybutyrate regulates milk fat and milk protein synthesis
    Chen J; Lin T; Zhang S; Yue X; Liu X; Wu C; Liang Y; Zeng X; Ren M; Chen F; Guan W; Zhang S
    Food Funct; 2023 Mar; 14(6):2642-2656. PubMed ID: 36866679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized, Placebo-Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High-Density Lipoprotein Cholesterol in Subjects With Dyslipidemia.
    Olson EJ; Mahar KM; Haws TF; Fossler MJ; Gao F; de Gouville AC; Sprecher DL; Lepore JJ
    Clin Pharmacol Drug Dev; 2019 Oct; 8(7):871-883. PubMed ID: 31268250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing.
    Sakurai T; Davenport R; Stafford S; Grosse J; Ogawa K; Cameron J; Parton L; Sykes A; Mack S; Bousba S; Parmar A; Harrison D; Dickson L; Leveridge M; Matsui J; Barnes M
    Eur J Pharmacol; 2014 Mar; 727():1-7. PubMed ID: 24486398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internalization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3.
    Li G; Shi Y; Huang H; Zhang Y; Wu K; Luo J; Sun Y; Lu J; Benovic JL; Zhou N
    J Biol Chem; 2010 Jul; 285(29):22605-18. PubMed ID: 20460384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation.
    Yang S; Li X; Wang N; Yin G; Ma S; Fu Y; Wei C; Chen Y; Xu W
    Ann Clin Lab Sci; 2015; 45(3):315-22. PubMed ID: 26116596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A).
    Kostylina G; Simon D; Fey MF; Yousefi S; Simon HU
    Cell Death Differ; 2008 Jan; 15(1):134-42. PubMed ID: 17932499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials.
    Lukasova M; Hanson J; Tunaru S; Offermanns S
    Trends Pharmacol Sci; 2011 Dec; 32(12):700-7. PubMed ID: 21944259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.
    Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V
    Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrate.
    Hepler C; Foy CE; Higgins MR; Renquist BJ
    Am J Physiol Regul Integr Comp Physiol; 2016 May; 310(10):R992-8. PubMed ID: 26936786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G).
    Tunaru S; Lättig J; Kero J; Krause G; Offermanns S
    Mol Pharmacol; 2005 Nov; 68(5):1271-80. PubMed ID: 16099840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.